Johnson & Johnson sues Biden administration to stop Medicare from negotiating its own drug prices

Johnson & Johnson (NYSE:JNJ) is suing the US government in a bid to block a program that would give the government health insurance program Medicare the ability to negotiate for lower drug prices. J&J is the latest major drugmaker to sue the Biden administration, joining Merck and Bristol Myers Squibb. The lobbyist group Pharmaceutical Research and Manufacturers of America have…